Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Liver Cancer|August 20, 2021
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular CarcinomaFrancesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, et al.
Seminars in Oncology|June 10, 2025
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world populationFrancesco Vitiello, Toshifumi Tada, Goki Suda, et al.
Hepatology (Baltimore, Md.)|February 26, 2026
Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world studyFrancesco Tovoli, Massimo Iavarone, Giuseppe Cabibbo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 11, 2018
Metabolic disorders across hepatocellular carcinoma in ItalyFilomena Morisco, Maria Guarino, Maria R Valvano, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environmentAlessandro Cucchetti, Annagiulia Gramenzi, Philip Johnson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2022
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinomaEdoardo G Giannini, Giulia Pieri, Sara Labanca, et al.
Liver Cancer|January 2, 2023
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT StudyAndrea Casadei-Gardini, Margherita Rimini, Masatoshi Kudo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 22, 2025
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus BevacizumabLeonardo Stella, Giuseppe Cabibbo, Ciro Celsa, et al.
Liver Cancer|June 26, 2025
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-BevacizumabBernardo Stefanini, Fabio Piscaglia, Fabio Marra, et al.
Liver Cancer|May 12, 2021
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationClaudia Campani, Alessandro Vitale, Gabriele Dragoni, et al.
Pageof 13